Euro area vs Rwanda: Access to anti-retroviral drugs, male
Euro area
87.0%
in 2022
Rwanda
95.0%
in 2024
Euro area rank
1st
Rwanda rank
4th
Access to anti-retroviral drugs, male over time
- Euro area
- Rwanda
How they compare
Rwanda currently reports 95.0% against 87.0% in Euro area, a difference of 8.0%.
That makes Rwanda's figure about 1.1 times Euro area's.
The two have swapped places 1 time across 23 shared years of data; in 2000 it was Euro area ahead.
Euro area ranks 1st and Rwanda ranks 4th of 19 groups.
Across the 3 decades both report, Euro area averaged higher in 2 and Rwanda in 1.
Head to head by decade
| Decade | Euro area | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.7% | 10.4% | 40.3% | Euro area |
| 2010s | 75.2% | 60.0% | 15.2% | Euro area |
| 2020s | 86.1% | 87.0% | 0.9% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Euro area or Rwanda?
- Rwanda, at 95.0% against 87.0% in Euro area as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Euro area and Rwanda?
- 8.0%, with Rwanda ahead.
- How many years of comparable data are there for Euro area and Rwanda?
- 23 years are reported by both, from 2000 to 2022.
- How do Euro area and Rwanda rank globally for access to anti-retroviral drugs, male?
- Euro area ranks 1st and Rwanda ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.